dr. reddy's labs glp-1 receptor agonist weight management diabetes treatments title Today we launch, Obeda®, India's first DCGI-approved generic semaglutide injection for Type 2 Diabetes. This product reinforces our purpose of good health cant wait, to bring high quality and affordable treatment Weight Reduction with GLP-1 Agonists
Pay in 4 interest-free payments of $5.68 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
























